Baker Brothers Advisors buy 5.33M shares of Idera Pharmaceuticals A filing by Idera Pharmaceuticals director Julian Baker showed that his Baker Bros. Advisors purchased about 5.33M shares of the company's stock in transactions on February 13 at an average price of $3.75 per shares. Idera Pharmaceutical shares are up 6.5% to $4.37 in early trading.